Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5Cholangiocarcinoma 4Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Colonic Neoplasms 1Cirrhosis, Familial, with Pulmonary Hypertension 1Carcinoma, Pancreatic Ductal 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Adrenocortical Carcinoma 1Adrenal Gland Neoplasms 1Adrenal Cortex Neoplasms 1

Interventions

Mitomycin 6Leucovorin 4Fluorouracil 4Oxaliplatin 3dehydroftorafur 2Mitozytrex 2Irinotecan 2Hyperthermic Intraperitoneal Chemotherapy 2Doxorubicin 2Cisplatin 2Biopsy 2surufatinib 1sodium thiosulfate 1sintilimab 1nilotinib 1irinotecan sucrosofate 1Surveys and Questionnaires 1Specimen Handling 1Platinum 1Pafolacianine 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Laparoscopy 1Immunoglobulin G 1Floxuridine 1Electrocardiography 1Disulfides 1Cytoreduction Surgical Procedures 1Cryotherapy 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Appendiceal Neoplasms × Floxuridine × 1 year × Clear all
NCT01815359 2026-02-05

ICARuS

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
292 enrolled
Gastrointestinal

Appendiceal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡